Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : SCOTTS LIQUID GOLD - NYSE sym SGD - Beats OPTIONS! -- Ignore unavailable to you. Want to Upgrade?

To: J R KARY who wrote (213)	4/23/1999 7:29:00 PM
From: J R KARY	Read Replies (1) \| Respond to of 222

Is 1Q's (.08) loss from cost of new Diabetic product license ? Its an up front , one time dealee paid by check to those French folks who have the know how on the NEW skin process . Sales are about the same for 4Q and SGD mentions the wood product advertising costs are down from last year . Here's something encouraging in 1Q's report: " ''Management is optimistic that a full-year of high-margin sales of our new skin care products will help to offset the maturation in demand for alpha hydroxy acid-based cosmetics, which is not unique to Scott's Liquid Gold,'' concluded Goldstein. " biz.yahoo.com ----------- Somewhere in the 10 K or annual report I saw that SGD was looking into using the French process used in the new diabetic product for all its skin care line . Could be a big plus if it give's SGD something to advertise about. Still need some chicks in the advts ! Jim K.